MMP2 and schizophrenia: A previous study found that cerebrospinal fluid MMP-2 levels were positively associated with core symptoms, psychogenic anxiety, and somatic anxiety in patients with major depressive disorder, but no correlation between cerebrospinal fluid MMP-2 and psychopathological symptoms was observed in patients with schizophrenia [30].